A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Evan M. Hersh, Steven J. O'Day, John Powderly, Khuda D. Khan, Anna C. Pavlick, Lee D. Cranmer, Wolfram E. Samlowski, Geoffrey M. Nichol, Michael J. Yellin, Jeffrey S. Weber

Research output: Contribution to journalArticle

218 Scopus citations

Fingerprint Dive into the research topics of 'A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences